MAPKII Kinase Inhibitor

Hsp25 Kinase Inhibitor

Catalog No. SIH-120

0 out of 5 based on 0 customer ratings
CAS No.
Molecular Formula C61H113N21O6
SKU: SIH-120 Categories: ,

Clear
Product Name MAPKII Kinase Inhibitor
Description

Hsp25 Kinase Inhibitor

Purity >95%
Molecular Formula C61H113N21O6
Molecular Weight 1396.7
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO or H20
Source Synthetic
Appearance White Solid
Safety Phrases Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 - Do not breathe dust
S24/25 - Avoid contact with skin and eyes
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
Cite This Product MAPKII Kinase Inhibitor (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-120)

Biological Description

Research Areas Cancer, Heat Shock
Scientific Background MAPKII Kinase Inhibitor targets MAPKAP kinase II (MK2), a key component of the p38 MAPK pathway involved in cellular stress responses. MK2 is activated by various chemical and biological stressors, including oxidative stress, cytokines, and irradiation. In neurodegenerative disease research, MK2 has emerged as a therapeutic target due to its role in neuroinflammation—a hallmark of conditions such as Alzheimer's and Parkinson's disease. By inhibiting MK2, this compound may attenuate inflammatory signaling cascades and reduce neuronal damage. Its modulation of stress-activated pathways positions it as a promising candidate for intervention in neuroinflammatory and neurodegenerative disorders.
References 1. Pearson G. et al. (2001). Endocrine Reviews 22 (2): 153-183.
2. Fan Y., et al. (2007) Mol. Cells 23 (1): 30-38.
3. Deng et al. (2003) Cell 115: 61-70.

Product Images

Currently there are no images for this product

Reviews

Reviews

There are no reviews yet.

Be the first to review “MAPKII Kinase Inhibitor”

Your email address will not be published. Required fields are marked *